Lars Viktrup

6.4k total citations
151 papers, 4.6k citations indexed

About

Lars Viktrup is a scholar working on Rheumatology, Urology and Psychiatry and Mental health. According to data from OpenAlex, Lars Viktrup has authored 151 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Rheumatology, 60 papers in Urology and 45 papers in Psychiatry and Mental health. Recurrent topics in Lars Viktrup's work include Urinary Bladder and Prostate Research (60 papers), Pelvic floor disorders treatments (43 papers) and Hormonal and reproductive studies (32 papers). Lars Viktrup is often cited by papers focused on Urinary Bladder and Prostate Research (60 papers), Pelvic floor disorders treatments (43 papers) and Hormonal and reproductive studies (32 papers). Lars Viktrup collaborates with scholars based in United States, United Kingdom and Denmark. Lars Viktrup's co-authors include Gunnar Lose, Claus G. Roehrborn, Albert Elion‐Mboussa, Kevin T. McVary, François Giuliano, Lei Xu, Ilker Yalcin, David A. Cox, Vincenzo Mirone and Leslie Tive and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Lars Viktrup

144 papers receiving 4.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Viktrup United States 39 2.4k 2.1k 1.4k 1.2k 999 151 4.6k
Jens Peter Nørgaard Denmark 35 3.0k 1.3× 1.4k 0.7× 299 0.2× 471 0.4× 604 0.6× 108 4.1k
Kenneth M. Peters United States 46 4.5k 1.9× 3.6k 1.7× 762 0.5× 174 0.1× 1.1k 1.1× 197 5.7k
Karl J. Kreder United States 36 3.0k 1.3× 2.7k 1.3× 464 0.3× 138 0.1× 1.1k 1.2× 175 4.4k
Apostolos Apostolidis Greece 33 2.8k 1.2× 2.0k 1.0× 615 0.4× 256 0.2× 502 0.5× 118 3.6k
Eric S. Rovner United States 36 3.5k 1.5× 3.1k 1.5× 165 0.1× 218 0.2× 1.2k 1.2× 134 4.5k
Victor W. Νitti United States 49 6.9k 2.9× 6.6k 3.2× 281 0.2× 253 0.2× 2.1k 2.1× 268 8.5k
Giris Jacob Israel 31 224 0.1× 113 0.1× 608 0.4× 301 0.3× 1.8k 1.8× 93 3.9k
Jaclyn Bergstrom United States 26 225 0.1× 125 0.1× 234 0.2× 890 0.8× 146 0.1× 53 2.1k
Colomba Falcone Italy 33 110 0.0× 134 0.1× 324 0.2× 911 0.8× 641 0.6× 104 3.3k
Mark H. Edwards United Kingdom 30 52 0.0× 1.3k 0.6× 378 0.3× 107 0.1× 860 0.9× 80 3.6k

Countries citing papers authored by Lars Viktrup

Since Specialization
Citations

This map shows the geographic impact of Lars Viktrup's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Viktrup with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Viktrup more than expected).

Fields of papers citing papers by Lars Viktrup

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Viktrup. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Viktrup. The network helps show where Lars Viktrup may publish in the future.

Co-authorship network of co-authors of Lars Viktrup

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Viktrup. A scholar is included among the top collaborators of Lars Viktrup based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Viktrup. Lars Viktrup is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Soyoung, Tuhina Neogi, S. Reza Jafarzadeh, et al.. (2025). Association of Pain During Exercise With Exercise‐Induced Hypoalgesia in People With Knee Osteoarthritis. Arthritis Care & Research. 77(7). 900–905. 1 indexed citations
3.
Lampl, Christian, Elizabeth K. Seng, Maurice Vincent, et al.. (2024). Interictal burden in migraine patients at the outset of CGRP monoclonal antibody prevention. The Journal of Headache and Pain. 25(1). 220–220. 3 indexed citations
4.
Schnitzer, Thomas J., Philip G. Conaghan, Francis Bérenbaum, et al.. (2024). Effect size varies based on calculation method and may affect interpretation of treatment effect: an illustration using randomised clinical trials in osteoarthritis. Advances in Rheumatology. 64(1). 31–31. 1 indexed citations
5.
Schnitzer, Thomas J., R.L. Robinson, Lars Viktrup, et al.. (2023). Opioid Prescribing for Osteoarthritis: Cross-Sectional Survey among Primary Care Physicians, Rheumatologists, and Orthopaedic Surgeons. Journal of Clinical Medicine. 12(2). 589–589. 2 indexed citations
6.
Rose, Michael, Tuhina Neogi, Michael P. LaValley, et al.. (2023). Reliability of Wearable Sensors for Assessing Gait and Chair Stand Function at Home in People With Knee Osteoarthritis. Arthritis Care & Research. 75(9). 1939–1948. 6 indexed citations
7.
Schnitzer, Thomas J., R.L. Robinson, Lars Viktrup, et al.. (2023). Opioids for Osteoarthritis: Cross-Sectional Survey of Patient Perspectives and Satisfaction. Journal of Clinical Medicine. 12(7). 2733–2733. 1 indexed citations
8.
Colloca, Luana, Robert H. Dworkin, John T. Farrar, et al.. (2023). Predicting Treatment Responses in Patients With Osteoarthritis: Results From Two Phase III Tanezumab Randomized Clinical Trials. Clinical Pharmacology & Therapeutics. 113(4). 878–886. 9 indexed citations
9.
Mease, Philip J., Louis Kuritzky, Wendy L. Wright, et al.. (2022). Efficacy and safety of tanezumab, NSAIDs, and placebo in patients with moderate to severe hip or knee osteoarthritis and a history of depression, anxiety, or insomnia: post-hoc analysis of phase 3 trials. Current Medical Research and Opinion. 38(11). 1909–1922. 6 indexed citations
10.
D’Arcy, Yvonne, Patrick W. Mantyh, Tony L. Yaksh, et al.. (2021). Treating osteoarthritis pain: mechanisms of action of acetaminophen, nonsteroidal anti-inflammatory drugs, opioids, and nerve growth factor antibodies. Postgraduate Medicine. 133(8). 879–894. 44 indexed citations
11.
Perrot, Serge, Michael J. Doane, Dena H. Jaffe, et al.. (2021). Burden of chronic low back pain: Association with pain severity and prescription medication use in five large European countries. Pain Practice. 22(3). 359–371. 14 indexed citations
12.
Mantyh, Patrick W., et al.. (2020). Nerve Growth Factor Signaling and Its Contribution to Pain. SHILAP Revista de lepidopterología. 6 indexed citations
13.
Bessette, Louis, Thomas J. Schnitzer, A Khan, et al.. (2019). Onset and maintenance of efficacy of subcutaneous tanezumab in patients with moderate to severe osteoarthritis of the knee or hip. Osteoarthritis and Cartilage. 27. S85–S86. 1 indexed citations
16.
17.
Thor, Karl B., Michael Kirby, & Lars Viktrup. (2007). Serotonin and noradrenaline involvement in urinary incontinence, depression and pain: scientific basis for overlapping clinical efficacy from a single drug, duloxetine. International Journal of Clinical Practice. 61(8). 1349–1355. 68 indexed citations
18.
Viktrup, Lars, et al.. (2007). Neurofisiología del tracto urinario inferior y de la continencia urinaria. Revista Mexicana de Urología. 67(3). 154–159. 2 indexed citations
19.
Viktrup, Lars, Guri Rørtveit, & Gunnar Lose. (2006). Risk of Stress Urinary Incontinence Twelve Years After the First Pregnancy and Delivery. Obstetrics and Gynecology. 108(2). 248–254. 117 indexed citations
20.
Viktrup, Lars. (2002). FEMALE STRESS AND URGE INCONTINENCE IN FAMILY PRACTICE: INSIGHT INTO THE LOWER URINARY TRACT. International Journal of Clinical Practice. 56(9). 694–700. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026